PATENT CLAIM ANALYSIS

Application Number: 16097506
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "338000"]

Abstract:
The present invention relates to crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.

Claim (Index 7):
A pharmaceutical composition comprising only one of the crystalline forms selected from the group consisting of hydrate, anhydrate and formamide solvate of the compound of formula (I) mainly and no significant fractions of another form of the compound of the formula (I).

Metadata:
- Claim Count in Document: 42.0
- Percentile: 97.0
- Lexical Diversity: 1.30556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16097463', '16097065', '15529996', '15106073', '13856666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7254276974879432
- 35 USC 102 Novelty (BERT): 0.5240375719651084
- Combined Prediction Score: 0.7052886849356598
- Mean Citation Score: 266.679436
- Max Citation Score: 294.3370700000001
- Similarity Product: 159.74158537584788

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test